```html

Asymptomatic Bacteriuria

What is Asymptomatic Bacteriuria?

Asymptomatic bacteriuria (ABU) is the presence of bacteria in the urine — ≥ 10⁵ colony‑forming units per milliliter (CFU/mL) on a clean‑catch specimen — without any of the typical urinary‑tract infection (UTI) symptoms such as dysuria, frequency, urgency, suprapubic pain, or fever. In other words, the urinary tract is colonized by bacteria, but the person feels well.

ABU is common, especially in certain populations: up to 5 % of healthy non‑pregnant women, 1–2 % of healthy men, and up to 10‑20 % of pregnant women. It is also seen frequently in the elderly, patients with indwelling catheters, and those with neurogenic bladder dysfunction. Because the condition is silent, it is usually discovered incidentally during routine urine testing for another reason.

Most guidelines (e.g., Infectious Diseases Society of America, American College of Obstetricians and Gynecologists) recommend not treating ABU in the majority of adults, as antibiotics provide no benefit and may promote resistance. Treatment is reserved for specific high‑risk groups, most notably pregnant women and patients undergoing certain urologic procedures.

Common Causes

ABU is not a disease caused by a single factor; rather, it reflects circumstances that allow bacteria to colonize the urinary tract without provoking an inflammatory response. The most frequent contributors include:

• Pregnancy – hormonal changes and urinary stasis increase colonization risk.
• Indwelling urinary catheters – provide a direct conduit for bacteria.
• Neurogenic bladder – impaired emptying leads to urine retention.
• Chronic urinary obstruction – e.g., benign prostatic hyperplasia (BPH) in men.
• Diabetes mellitus – glucosuria and autonomic neuropathy favor bacterial growth.
• Elderly age – reduced immunity and higher prevalence of catheter use.
• Prior urinary‑tract instrumentation – cystoscopy, stent placement, or surgery.
• Spinal cord injury – altered bladder dynamics and frequent catheterization.
• Immunosuppression – transplant recipients or patients on chronic steroids.
• Female anatomy – shorter urethra predisposes to colonization, especially in sexually active women.

Associated Symptoms

By definition, ABU does not cause urinary‑tract symptoms. However, clinicians may notice accompanying findings that can be mistaken for other conditions:

• Positive urine dipstick for leukocyte esterase or nitrites, despite lack of dysuria.
• Microscopic pyuria (white blood cells in urine) in the absence of pain.
• Occasional mild flank tenderness in patients with structural abnormalities, though true pain is rare.
• In pregnant women, ABU is linked to an increased risk of developing a symptomatic UTI later in pregnancy.

When to See a Doctor

Because ABU itself is silent, most people discover it incidentally. Still, medical evaluation is warranted when any of the following arise:

• Development of urinary symptoms (painful urination, urgency, frequency, hematuria).
• Fever, chills, or flank pain suggestive of ascending infection or pyelonephritis.
• Pregnancy – routine prenatal urine cultures should be reviewed; positive results always need follow‑up.
• Recent placement of a urinary catheter or recent urologic procedure.
• Underlying conditions that increase the risk of complications (e.g., diabetes, immunosuppression).

Diagnosis

Accurate diagnosis hinges on proper specimen collection and interpretation of culture results:

1. Midstream clean‑catch urine specimen – collected after genital cleansing to avoid contamination.
2. Urine culture – the gold standard. ABU is defined as:
   • ≥ 10⁵ CFU/mL of a single organism in a clean‑catch specimen (women).
   • ≥ 10⁴ CFU/mL in men (due to higher contamination risk).
   • Any growth ≥ 10³ CFU/mL in patients with indwelling catheters, provided the same organism is isolated on two consecutive samples taken ≥ 48 hours apart.
3. Urine dipstick – may be positive for leukocyte esterase or nitrites, but this alone cannot confirm ABU.
4. Review of symptoms – a thorough history ensures the patient truly lacks urinary complaints.
5. Additional testing (selected cases) – renal ultrasound or CT if structural abnormalities are suspected; blood work (CBC, creatinine) in complicated patients.

Reference: Infectious Diseases Society of America (IDSA) guideline on asymptomatic bacteriuria, 2019; CDC UTI Fact Sheet, 2022.

Treatment Options

Therapy is individualized based on patient risk. The overarching principle is “do not treat unless indicated.”

When Treatment Is Recommended

• Pregnant women – to prevent pyelonephritis, preterm labor, and low birth weight. First‑line agents:
  • Amoxicillin‑clavulanate 500/125 mg PO q12h for 3‑7 days, or
  • Nitrofurantoin 100 mg PO q6h for 5‑7 days (avoid near term < 38 weeks because of risk of hemolysis in newborns).
• Patients undergoing urologic procedures that breach the urinary mucosa (e.g., transurethral resection of the prostate, stone removal). Typical regimen: a single dose of a fluoroquinolone (e.g., ciprofloxacin 500 mg PO) or a 3‑day course of trimethoprim‑sulfamethoxazole.
• Renal transplant recipients within the first month post‑transplant (center‑specific protocols).

When to Withhold Antibiotics

• Healthy non‑pregnant adults (both men and women) – treatment does not reduce risk of symptomatic infection and contributes to antimicrobial resistance.
• Elderly patients in long‑term care facilities without urinary symptoms – routine screening and treatment are not recommended.

Supportive/ Home Measures (for all patients)

• Maintain adequate hydration (≥ 2 L water/day) to promote regular bladder emptying.
• Practice proper perineal hygiene: front‑to‑back wiping, cotton underwear, and avoidance of irritants.
• Scheduled voiding (every 3–4 hours) in patients with neurogenic bladder or limited mobility.
• Review and minimize indwelling catheter use; if a catheter is necessary, ensure sterile insertion and regular changes per protocol.

Prevention Tips

Although ABU cannot be eliminated entirely, the following strategies reduce the chance of bacterial colonisation turning into a symptomatic infection:

• Limit catheter use – use intermittent (straight) catheterization instead of a chronic indwelling catheter when feasible.
• Catheter care – maintain a closed drainage system, change catheters only when indicated, and keep the collection bag below bladder level.
• Hydration – aim for at least 1.5–2 L of urine output daily unless contraindicated.
• Bladder training – for patients with incomplete emptying, timed voiding and pelvic floor exercises can improve clearance.
• Prophylactic antibiotics are NOT recommended for preventing ABU, except in the specific scenario of pregnancy or pre‑operative urologic surgery.
• Manage comorbidities – optimal control of diabetes, weight, and post‑void residual volumes.
• Urine hygiene – promptly empty the bladder after intercourse; avoid spermicidal products that may disrupt normal flora.
• Regular prenatal screening – all pregnant women should have a urine culture at 12‑16 weeks gestation.

Emergency Warning Signs

Key Take‑aways

• Asymptomatic bacteriuria is the presence of bacteria in urine without urinary symptoms.
• It is common in pregnant women, the elderly, catheterized patients, and those with bladder dysfunction.
• Routine treatment is not recommended for most individuals; over‑use of antibiotics can cause resistance.
• Pregnant women and patients undergoing certain urologic procedures should receive targeted therapy.
• Staying hydrated, proper catheter care, and managing underlying health conditions are the best prevention strategies.
• Urgent medical care is needed if fever, flank pain, or new urinary symptoms appear.

For more detailed guidance, consult the latest IDSA clinical practice guideline on asymptomatic bacteriuria and discuss any concerns with your primary‑care provider or urologist.

```